MDxHealth SA (MDXH)
0.1833
0.00 (0.00%)
USD |
NASDAQ |
Oct 23, 16:00
0.1886
+0.01
(+2.89%)
After-Hours: 20:00
MDxHealth Enterprise Value : 96.05M for Oct. 23, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 96.05M |
| October 22, 2026 | 96.09M |
| October 21, 2026 | 97.67M |
| October 20, 2026 | 96.62M |
| October 19, 2026 | 96.05M |
| October 16, 2026 | 97.25M |
| October 15, 2026 | 117.64M |
| October 14, 2026 | 119.09M |
| October 13, 2026 | 120.54M |
| October 12, 2026 | 117.66M |
| October 09, 2026 | 116.93M |
| October 08, 2026 | 116.46M |
| October 07, 2026 | 117.45M |
| October 06, 2026 | 117.45M |
| October 05, 2026 | 117.30M |
| October 02, 2026 | 115.97M |
| October 01, 2026 | 116.24M |
| September 30, 2026 | 116.67M |
| September 29, 2026 | 113.35M |
| September 28, 2026 | 114.79M |
| September 25, 2026 | 115.67M |
| September 24, 2026 | 116.53M |
| September 23, 2026 | 117.74M |
| September 22, 2026 | 117.45M |
| September 21, 2026 | 117.46M |
| Date | Value |
|---|---|
| September 18, 2026 | 119.00M |
| September 17, 2026 | 121.14M |
| September 16, 2026 | 121.60M |
| September 15, 2026 | 121.22M |
| September 14, 2026 | 122.96M |
| September 11, 2026 | 122.83M |
| September 10, 2026 | 121.36M |
| September 09, 2026 | 122.18M |
| September 08, 2026 | 123.29M |
| September 04, 2026 | 125.08M |
| September 03, 2026 | 123.94M |
| September 02, 2026 | 123.11M |
| September 01, 2026 | 123.64M |
| August 31, 2026 | 123.63M |
| August 28, 2026 | 123.66M |
| August 27, 2026 | 123.70M |
| August 26, 2026 | 125.48M |
| August 25, 2026 | 127.16M |
| August 24, 2026 | 124.72M |
| August 21, 2026 | 124.81M |
| August 20, 2026 | 123.62M |
| August 19, 2026 | 125.63M |
| August 18, 2026 | 125.22M |
| August 17, 2026 | 130.59M |
| August 14, 2026 | 128.14M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Myriad Genetics, Inc. | 651.69M |
| BioRestorative Therapies, Inc. | -1.494M |
| CareDx, Inc. | 3.209B |
| Natera, Inc. | 57.16B |
| Exagen, Inc. | 178.95M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -9.478M |
| Revenue (Quarterly) | 27.21M |
| Total Expenses (Quarterly) | 36.69M |
| EPS Diluted (Quarterly) | -0.2245 |
| Gross Profit Margin (Quarterly) | 61.13% |
| Profit Margin (Quarterly) | -34.83% |
| Earnings Yield | -399.9% |
| Normalized Earnings Yield | -399.89 |